Uganda mobilises diagnostics supplies and labs support in response to fever outbreak:
This article was originally published in Clinica
The Ugandan government is mobilising diagnostic testing and laboratory resources to stem an outbreak of Marburg haemorrhagic fever (MHF). The ministry of health (MoH) is acting to monitor and halt a possible spread of the infection beyond a single group of several cases, including one fatality, reported over the last month, according to a statement issued today by the World Health Organisation. The WHO is supporting the MoH with supplies and logistics efforts. The laboratory investigations are being carried out by the Uganda Virology Research Institute and the Kenya Medical Research Institute, backed by the Atlanta, US laboratory of the Centers for Disease Control and Prevention (CDC), where the definitive confirmation of MHF was made.
You may also be interested in...
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.
Manufacturers of endoscopic equipment, biofeedback devices and thermometers were among those cited for regulatory violations in US FDA warning letters this week. A total of four device-related enforcement missives were released by the agency.
The biopharma industry has struggled to recruit patients into clinical trials that adequately reflect the diverse patient populations they hope to reach with new products. Failure to improve minority subgroup participation now will cost trial sponsors later.